GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » Accumulated other comprehensive income (loss)

Danapha Pharmaceutical JSC (HSTC:DAN) Accumulated other comprehensive income (loss) : ₫0.00 Mil (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Danapha Pharmaceutical JSC Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Danapha Pharmaceutical JSC's Accumulated other comprehensive income (loss) for the quarter that ended in . 20 was ₫0.00 Mil.

Danapha Pharmaceutical JSC Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Danapha Pharmaceutical JSC's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danapha Pharmaceutical JSC Accumulated other comprehensive income (loss) Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Accumulated other comprehensive income (loss)

Danapha Pharmaceutical JSC Semi-Annual Data
Accumulated other comprehensive income (loss)

Danapha Pharmaceutical JSC Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Danapha Pharmaceutical JSC Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Danapha Pharmaceutical JSC's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Danapha Pharmaceutical JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
HSTC:MKP HSTC:DVM STC:DBT HSTC:GPC HSTC:DTH STC:DMC STC:TRA ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538
Traded in Other Exchanges
N/A
Address
253 Dung Si Thanh Khe, Da Nang, VNM
Website
http://www.danapha.com
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.